PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsvascular diseases
MeSH D014652 - vascular diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D002318:Cardiovascular diseases
3 Companies
15 Drugs
$
Success rate
D014652: 
Vascular diseases
1 Company
1 Drug
$
Success rate
D000071078:Pulmonary vein stenosis
0 Companies
0 Drugs
Success rate
D000783:Aneurysm
0 Companies
0 Drugs
Success rate
D000798:Angiomatosis
0 Companies
0 Drugs
Success rate
D000799:Angioedema
24 Companies
6 Drugs
$
Success rate
D001018:Aortic diseases
0 Companies
0 Drugs
Success rate
D001157:Arterial occlusive diseases
1 Company
1 Drug
$
Success rate
D001165:Arteriovenous malformations
0 Companies
0 Drugs
Success rate
D002561:Cerebrovascular disorders
0 Companies
0 Drugs
Success rate
D003161:Compartment syndromes
0 Companies
0 Drugs
Success rate
D003925:Diabetic angiopathies
8 Companies
1 Drug
$
Success rate
D006484:Hemorrhoids
98 Companies
25 Drugs
$
Success rate
D006504:Hepatic veno-occlusive disease
2 Companies
1 Drug
$
Success rate
D006940:Hyperemia
8 Companies
4 Drugs
$
Success rate
D006973:Hypertension
244 Companies
95 Drugs
$
Success rate
D007022:Hypotension
80 Companies
22 Drugs
$
Success rate
D010382:Peliosis hepatis
0 Companies
0 Drugs
Success rate
D011668:Pulmonary veno-occlusive disease
0 Companies
0 Drugs
Success rate
D012170:Retinal vein occlusion
7 Companies
2 Drugs
$
Success rate
D012587:Scimitar syndrome
0 Companies
0 Drugs
Success rate
D013159:Splenic infarction
0 Companies
0 Drugs
Success rate
D013479:Superior vena cava syndrome
0 Companies
0 Drugs
Success rate
D013684:Telangiectasis
0 Companies
0 Drugs
Success rate
D013901:Thoracic outlet syndrome
0 Companies
0 Drugs
Success rate
D014646:Varicocele
0 Companies
0 Drugs
Success rate
D014648:Varicose veins
5 Companies
2 Drugs
$
Success rate
D014657:Vasculitis
8 Companies
1 Drug
$
Success rate
D014689:Venous insufficiency
0 Companies
0 Drugs
Success rate
D015427:Reperfusion injury
0 Companies
0 Drugs
Success rate
D016157:Vascular fistula
0 Companies
0 Drugs
Success rate
D016491:Peripheral vascular diseases
46 Companies
23 Drugs
$
Success rate
D016769:Embolism and thrombosis
0 Companies
0 Drugs
Success rate
D016888:Angiodysplasia
0 Companies
0 Drugs
Success rate
D017091:Ischemic colitis
0 Companies
0 Drugs
Success rate
D017202:Myocardial ischemia
0 Companies
0 Drugs
Success rate
D018917:Ischemic optic neuropathy
0 Companies
0 Drugs
Success rate
D019043:Vascular neoplasms
0 Companies
0 Drugs
Success rate
D019559:Capillary leak syndrome
0 Companies
0 Drugs
Success rate
D020141:Hemostatic disorders
1 Company
1 Drug
$
Success rate
D020758:Spinal cord vascular diseases
0 Companies
0 Drugs
Success rate
D053421:Hand-arm vibration syndrome
0 Companies
0 Drugs
Success rate
D056987:Vasoplegia
0 Companies
0 Drugs
Success rate
D057772:Vascular system injuries
0 Companies
0 Drugs
Success rate
D058246:Prehypertension
0 Companies
0 Drugs
Success rate
D065666:Mesenteric ischemia
0 Companies
0 Drugs
Success rate
D000094667:Penetrating atherosclerotic ulcer
0 Companies
0 Drugs
Success rate
D017541:False aneurysm
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
29%
2/7
Phase 2
43%
15/35
Phase 3
15%
5/34
Approved: 1Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bristol Myers Squibb
Idecabtagene vicleucel,
Vitamin k
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use